Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥732.1B | ¥739.1B | −0.9% |
| Operating Income | ¥42.9B | ¥46.6B | −7.9% |
| Ordinary Income | ¥52.5B | ¥54.2B | −3.1% |
| Net Income | ¥34.5B | ¥39.8B | −13.3% |
| ROE | 4.2% | 5.0% | - |
Executive Summary
This period saw a decline in Operating Income that exceeded the decrease in Revenue, as the increase in profit from the Gas Business was insufficient to offset deterioration in the Chemicals Business and Other Businesses. Revenue was ¥732.1B (前年比-0.9%), Operating Income was ¥42.9B (同-7.9%), Ordinary Income was ¥52.5B (同-3.1%), and Net Income attributable to owners of the parent was ¥34.5B (同-13.3%). Ordinary Income was supported by non-operating income (dividend income of ¥3.9B and foreign exchange gains of ¥1.6B), which narrowed the decline in Operating Income; however, the decline in Net Income widened due to the tax burden and net extraordinary losses of ¥0.97B.
Factors Affecting Performance
【Revenue】Revenue was ¥732.1B, down 0.9% year on year. The core Gas Business generated ¥541.5B (composition ratio: 74.0%, 同-0.8%), the Chemicals Business generated ¥164.3B (composition ratio: 22.4%, approximately flat), and Other Businesses generated ¥26.2B (composition ratio: 3.6%, 同-8.3%); no segment achieved Revenue growth.
【Profit and Loss】Operating Income was ¥42.9B (同-7.9%), and the Operating Income Margin declined to 5.9% from approximately 6.3% in the previous year. While the Gas Business improved to profit of ¥49.4B (同+0.5%) and a profit margin of 9.1%, the Chemicals Business declined to profit of ¥6.5B (同-12.8%) and a profit margin of 4.0%, while Other Businesses turned to a loss of ¥0.6B. In addition, unallocable corporate expenses increased to ¥12.4B (同+21.2%), putting further downward pressure on consolidated Operating Income beyond the slight decline in total segment profit. Ordinary Income was ¥52.5B (同-3.1%), supported by non-operating income (dividend income and foreign exchange gains), thereby containing the decline; however, Net Income was ¥34.5B (同-13.3%) due to extraordinary losses (including impairment losses of ¥0.4B) and the tax burden. In conclusion, both Revenue and profit declined.
Segment Analysis
Even amid declining Revenue, the Gas Business improved profit to ¥49.4B (同+0.5%) and its profit margin to 9.1% (同+approximately 0.1pt), making it the core business and accounting for 89.3% of total segment profit of ¥55.3B. Despite approximately flat Revenue, the Chemicals Business declined to profit of ¥6.5B (同-12.8%) and a profit margin of 4.0% (同-0.6pt), indicating deterioration in profitability. Other Businesses generated Revenue of ¥26.2B (同-8.3%) and turned to a loss of ¥0.6B, shifting from the previous year's profit of ¥0.2B to a loss. Corporate expenses expanded to ¥12.4B (同+21.2%), offsetting the benefit from increased profit in the Gas Business and amplifying the decline in consolidated Operating Income.
Key Financial Metrics
【Profitability】Operating Income Margin of 5.9%, Ordinary Income Margin of 7.2%, and Net Income Margin of 4.7% all declined from the same period of the previous year (6.3%, 7.3%, and 5.4%, respectively), while ROE remained at 4.2%. The low Net Income Margin and total asset turnover are constraints on profitability, and the earnings structure is not dependent on financial leverage.【Cash Quality】Cash and deposits were ¥297.6B, while interest-bearing debt was ¥118.9B, indicating a substantial net cash position. Accounts receivable and notes receivable were ¥191.0B, making collection management, including electronically recorded monetary claims, important.【Investment Efficiency】Investment securities were ¥156.8B, accounting for 12.5% of total assets, with unrealized gains including ¥75.1B in valuation difference on securities.【Financial Soundness】The Equity Ratio was high at 66.0%. Current assets of ¥646.9B substantially exceeded current liabilities of ¥279.4B, indicating a conservative and stable financial foundation.
Cash Flow Analysis
Although detailed disclosure of the statement of cash flows is not available, the balance sheet trends indicate ample financial capacity. Cash and deposits were ¥297.6B, remaining approximately flat from ¥299.9B in the same period of the previous year, and the Company maintained a substantial net cash position, significantly exceeding interest-bearing debt of ¥118.9B. Current assets of ¥646.9B exceeded current liabilities of ¥279.4B by ¥367.5B, indicating substantial working capital. Meanwhile, customer credit exposure was significant, with accounts receivable and notes receivable of ¥191.0B plus electronically recorded monetary claims of ¥90.3B; trends in collection periods could affect the speed of cash conversion. Net extraordinary losses were small at ¥0.97B, indicating that the current-period profit level was not substantially boosted by temporary factors.
Earnings Quality
Ordinary Income was ¥52.5B, consisting of Operating Income of ¥42.9B plus non-operating income of ¥12.2B (dividend income of ¥3.9B, foreign exchange gains of ¥1.6B, and other income of ¥5.8B), less non-operating expenses of ¥2.7B (including interest expenses of ¥0.6B), representing a structure with somewhat high dependence on non-operating income. Against extraordinary income of ¥0.1B from the sale of investment securities, extraordinary losses were ¥1.1B (including impairment losses of ¥0.4B), resulting in a net loss of ¥0.97B and slightly reducing Profit Before Tax of ¥51.5B. These extraordinary losses represented approximately 2.8% of Net Income of ¥34.5B, indicating low dependence on temporary factors, with most profit generated by recurring business activities. However, comprehensive income was ¥45.3B, exceeding Net Income, supported by a ¥13.3B increase in valuation difference on securities; the divergence between Net Income and comprehensive income was largely attributable to changes in the market value of held shares.
Earnings Forecast and Guidance
The Full-Year forecast is Revenue of ¥1020.0B (前年比+3.0%), Operating Income of ¥63.0B (同+5.5%), and Ordinary Income of ¥71.0B (同+6.8%), with no forecast revisions during the period. The Q3 cumulative progress rates were 71.8% for Revenue, 68.1% for Operating Income, and 73.9% for Ordinary Income, with progress in Operating Income slightly below the standard 75% level. To achieve the Full-Year plan, approximately ¥20.1B in Operating Income and an Operating Income Margin of approximately 7.0% will be required in Q4, necessitating improvement from the cumulative margin of 5.9%.
Shareholder Returns
The Q2 dividend was ¥20.00 per share, and the Full-Year forecast annual dividend is ¥40.00 (year-end dividend of ¥20.00), with no revisions to the dividend forecast during the period. Based on forecast Net Income of ¥45.0B for the Full Year, the forecast Payout Ratio is approximately 49.1%. With retained earnings of ¥679.4B and cash and deposits of ¥297.6B, the Company has substantial financial capacity and a high ability to maintain its dividend.
Risk Factors
-
Deterioration in the profitability of the Chemicals Business: Despite approximately flat Revenue, segment profit declined to ¥6.5B (同-12.8%) and the profit margin fell to 4.0%. Raw material and energy costs and the status of price pass-through will determine future profitability.
-
Concentration of profit in the Gas Business: The Gas Business accounts for 89.3% of total segment profit of ¥55.3B. Changes in industrial gas demand, fuel costs, and the operating conditions of major customers could have a significant impact on consolidated earnings.
-
Other Businesses turning loss-making and increase in corporate expenses: Other Businesses turned to a loss of ¥0.6B, while corporate expenses expanded to ¥12.4B (同+21.2%). This creates a structure in which improvements at the segment level are less likely to flow through to consolidated profit.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 5.9% | 8.6% (4.3%–12.7%) | −2.7pt |
| Net Income Margin | 4.7% | 6.4% (2.8%–10.3%) | −1.7pt |
Both profitability metrics are below the industry median, placing the Company at a relatively low level within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (Year on Year) | −0.9% | 3.3% (-2.1%–8.9%) | −4.2pt |
Revenue growth was 4.2pt below the industry median, positioning the Company as a business experiencing a decline in Revenue within the industry.
※Source: Compiled by the Company
Key Points from the Earnings Results
-
While the Gas Business achieved increased profit and an improved profit margin despite declining Revenue and continued to function as the core of consolidated earnings, lower profitability in the Chemicals Business, Other Businesses turning loss-making, and increased corporate expenses reduced the consolidated Operating Income Margin by approximately 0.45pt year on year.
-
Achieving the Full-Year Operating Income forecast of ¥63.0B will require an Operating Income Margin of approximately 7.0% in Q4, exceeding the cumulative actual margin of 5.9%; progress toward the target will be a key focus going forward.
-
The financial foundation is conservative and robust, as evidenced by an Equity Ratio of 66.0%, a net cash position, and a high current ratio, supporting resilience to earnings volatility and the ability to maintain dividends.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear（Bearish） | 1,315円 |
| base（Base） | 1,335円 |
| bull（Bullish） | 1,351円 |
| Calculation Assumption | Value |
|---|---|
| Book Value Per Share (BPS) | 1,495円 |
| Adjusted Forecast EPS | 87.0円 |
| Cost of Equity r | 9.77%（10-year government bond 2.77% + equity risk premium 6.00% + size premium 1.00%） |
| Residual Income Persistence Factor ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 49.4% |
| Forecast EPS Confidence Adjustment | ×1.075（based on the track record of guidance achievement in the same industry） |
| Implied PBR / PER | 0.89倍 / 15.3倍 |
Sensitivity: 1,299円–1,373円 at Cost of Equity ±1%, and 1,330円–1,338円 at ω±0.1.
Notes:
- Since forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
- Net assets as of the quarter-end are used (there is a timing difference from the Full-Year forecast).
- Since net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
（Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices）
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting specialists as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was moderately weak at the operating level, with broadly flat revenue but profit contraction and a softer chemical-products contribution. Revenue declined 0.9% YoY to ¥73.21bn. Operating income fell 7.9% to ¥4.291bn. Ordinary income declined a more limited 3.1% to ¥5.248bn, supported by non-operating income of ¥1.223bn. Net income attributable to owners fell 13.6% to ¥3.416bn. The gross profit margin improved by 24bp YoY to 26.8%, as cost of sales declined 1.0%, slightly faster than revenue. However, the operating margin contracted by 44bp to 5.9% because SG&A expenses rose 2.4% to ¥15.345bn despite the revenue decline. The net margin compressed by roughly 68bp YoY to 4.7%. The gas business remained the core business, generating segment revenue of ¥54.155bn and segment profit of ¥4.936bn. Gas segment profit increased 0.5% YoY and its segment margin improved to 9.1%. Chemical-products revenue was nearly flat at ¥16.432bn, but segment profit fell 12.8% to ¥655m, reducing its margin to 4.0%. Other businesses recorded a segment loss of ¥61m, compared with a ¥20m profit a year earlier. Unallocated corporate expenses increased from ¥1.022bn to ¥1.239bn, amplifying the decline in consolidated operating profit. The year-on-year net-income decline was also affected by the absence of the prior year's ¥474m gain on sales of investment securities, while the current period included a ¥44m impairment loss. Balance-sheet liquidity remains strong, with cash of ¥29.760bn, a current ratio of 231.5%, and cash equal to 16.4 times short-term debt. Full-year guidance implies a meaningful Q4 recovery, particularly in revenue and operating income, while the unchanged forecast indicates that management retains confidence in achieving the plan.
Profitability Analysis
Reported ROE is 5.5%, below the 8% benchmark generally associated with a stronger return profile. The reported DuPont decomposition is net profit margin of 4.7% × asset turnover of 0.780 × financial leverage of 1.52x, resulting in ROE of 5.5%. The principal earnings pressure is margin-related rather than leverage-related: the operating margin declined to 5.9% from approximately 6.3% in the prior-year period, while the net margin fell to 4.7% from approximately 5.4%. Gross margin improved to 26.8% from approximately 26.6%, indicating that gross-profit resilience was preserved despite a 0.9% sales decline. The adverse operating leverage arose below gross profit, as SG&A increased 2.4% while revenue fell. This cost trend reduced operating income by 7.9%, materially faster than the revenue decline. The gas business is the earnings anchor, accounting for ¥4.936bn of the aggregate ¥5.530bn segment profit and delivering a 9.1% margin, up from 9.0% a year earlier. Chemical-products profitability weakened materially, with segment margin declining from 4.6% to 4.0%, suggesting pressure in product mix, pricing, or cost absorption. Other businesses moved to a loss, although its revenue contribution remains small. Corporate costs represented ¥1.239bn, or 28.9% of consolidated operating income, versus ¥1.022bn and 21.9% a year earlier, making overhead discipline an important determinant of margin recovery. Ordinary income exceeded operating income by ¥957m, supported by dividend income of ¥393m, foreign-exchange gains of ¥161m, and other non-operating income. The 1.20x interest burden is favorable in the narrow DuPont sense because pre-tax income exceeded EBIT, but it also shows that non-operating investment-related income has a meaningful influence on pre-tax earnings. Interest expense was only ¥62m and interest coverage was a very strong 69.21x, so financing cost is not constraining profitability. The effective tax rate was 33.0%, producing a tax burden of 0.663 and modestly limiting conversion of pre-tax profit into net profit.
Growth Assessment
Revenue declined 0.9% YoY to ¥73.21bn, reflecting a modest contraction rather than a severe demand downturn. The gas business declined 0.8% to ¥54.155bn, but segment profit rose 0.5%, demonstrating relative resilience and improved profitability in the largest business. Chemical-products revenue was effectively flat, down only 0.1% to ¥16.432bn, but its ¥96m segment-profit decline indicates that revenue stability has not translated into earnings stability. Other-business revenue declined 8.3% to ¥2.624bn and shifted into loss. Consolidated gross profit was nearly unchanged at ¥19.637bn, confirming that weaker growth was not principally driven by a deterioration in gross margin. The key issue is the conversion of gross profit into operating profit, given the increase in SG&A and unallocated corporate costs. Full-year guidance calls for revenue of ¥102.0bn, operating income of ¥6.3bn, ordinary income of ¥7.1bn, and net income attributable to owners of ¥4.5bn. Q3 cumulative progress is 71.8% for sales versus the standard 75%, 68.1% for operating income versus 75%, 73.9% for ordinary income versus 75%, and 75.9% for net income versus 75%. The operating-income progress shortfall of 6.9 percentage points is the main execution item entering Q4. Achieving guidance requires Q4 revenue of ¥28.789bn and operating income of ¥2.009bn, equivalent to a 7.0% quarterly operating margin, above the Q3 cumulative margin of 5.9%. The implied Q4 operating recovery is therefore dependent on improved cost absorption, chemical-products margin normalization, and control of corporate expenses. The unchanged guidance suggests management expects these factors to improve sufficiently in the final quarter.
Financial Health
Financial health is strong. Current assets of ¥64.691bn exceed current liabilities of ¥27.945bn by ¥36.746bn, producing a current ratio of 231.5% and a quick ratio of 218.2%. Cash and deposits of ¥29.760bn alone exceed short-term loans of ¥1.815bn by 16.4 times. Interest-bearing debt totals ¥11.890bn, comprising ¥1.815bn of short-term loans and ¥10.075bn of long-term loans. Cash exceeds total interest-bearing debt by ¥17.870bn, providing a net-cash position. Short-term debt represents only 15.3% of interest-bearing debt, limiting refinancing and maturity-mismatch risk. Debt-to-capital is a conservative 12.6%, while the reported debt-to-equity ratio is 0.52x; calculated interest-bearing debt relative to total equity is approximately 0.14x. Total equity increased ¥2.854bn YoY to ¥82.546bn, supported by retained earnings growth and higher valuation gains on securities. Owners' equity totals ¥81.735bn, equivalent to book value per share of ¥1,495.31. Interest coverage of 69.21x indicates considerable capacity to service debt even under a material earnings decline. Investment securities of ¥15.675bn represent 12.5% of total assets, making market-value movements and investee dividend income relevant to comprehensive income and non-operating earnings. Deferred tax liabilities increased to ¥3.625bn, consistent with the rise in unrealized valuation gains on securities.
Notable B/S Changes
Investment securities: +¥2.020bn (+14.8%) to ¥15.675bn, accompanied by a ¥1.319bn increase in valuation gains on securities; this strengthens equity but raises sensitivity to equity-market movements and dividend-income variability. Total equity: +¥2.854bn (+3.6%) to ¥82.546bn, reflecting retained-earnings accumulation and higher accumulated OCI; the stronger equity base supports conservative leverage. Retained earnings: +¥1.761bn (+2.7%) to ¥67.937bn, reinforcing internal funding capacity and dividend support. Accumulated other comprehensive income: +¥1.058bn (+14.7%) to ¥8.269bn, principally reflecting securities valuation movements; this increases the equity contribution from unrealized market gains. Deferred tax liabilities: +¥837m (+30.0%) to ¥3.625bn, consistent with the increase in unrealized gains on investment securities. Electronic receivables: +¥1.315bn (+17.0%) to ¥9.031bn; together with the DSO quality alert, collection efficiency remains an important working-capital monitoring item. Current liabilities: -¥1.523bn (-5.2%) to ¥27.945bn, improving the current ratio to 231.5% and strengthening near-term liquidity. Property, plant and equipment: +¥114m (+0.3%) to ¥42.097bn, indicating a broadly stable fixed-asset base; construction in progress increased ¥193m (+32.7%) to ¥783m, suggesting a modestly expanding investment pipeline.
Cash Flow Quality
Dividend Sustainability
The company has declared an interim dividend of ¥20.00 per share and maintains full-year DPS guidance of ¥40.00 per share. Based on full-year EPS guidance of ¥80.96, the prospective dividend payout ratio is approximately 49.4%, below the 60% sustainability benchmark. The interim DPS represents half of the indicated full-year dividend, implying a balanced interim and year-end distribution profile. Q3 cumulative EPS is ¥61.89, which already covers the ¥20.00 interim dividend by approximately 3.1 times. Retained earnings of ¥67.937bn provide a substantial capital buffer relative to the planned dividend. The conservative debt structure, net-cash position, and strong liquidity further support dividend-paying capacity. Dividend sustainability is nevertheless linked to delivery of the full-year earnings plan, as the company needs a stronger Q4 operating result to reach its operating-income guidance. There is no indicated dividend revision, so the ¥40.00 DPS outlook remains management's stated capital-return framework.
Risk Assessment
Business risks include Chemical-products profitability risk: segment profit declined 12.8% YoY to ¥655m despite broadly flat revenue, and the segment margin fell 58bp to 4.0%. This indicates sensitivity to selling prices, input costs, product mix, and plant utilization., Gas-business demand and energy-cost risk: the gas business is the core earnings source, contributing ¥4.936bn of segment profit. Its current resilience is positive, but a slowdown in industrial production, customer activity, or adverse energy and distribution-cost movements would have an outsized effect on consolidated earnings., Manufacturing working-capital risk: the quality alert identifies annualized DSO of 71 days, above the 60-day warning threshold. The root cause is slower collection relative to the benchmark; for an industrial gas and chemical supplier, extended customer-credit terms can occur in business-to-business channels, but it increases cash tied up in receivables. The impact is greater sensitivity of cash conversion and credit-loss exposure if customer conditions weaken., Foreign-exchange and investment-income volatility: foreign-exchange gains of ¥161m and dividend income of ¥393m supported ordinary income. These items are beneficial but less directly tied to underlying operating performance than gas and chemical segment earnings., Environmental and regulatory risk: industrial gas and chemical operations face continuing exposure to safety standards, hazardous-material handling, emissions regulation, and environmental compliance costs. A safety incident, compliance failure, or stricter regulation could affect operating continuity and costs..
Financial risks include Investment-security valuation risk: investment securities total ¥15.675bn, and valuation gains on securities increased to ¥7.512bn. Market-price declines could reduce OCI and equity, while lower investee distributions could pressure non-operating income., Final-quarter execution risk: operating-income progress is 68.1% against the standard 75% through Q3. The full-year target requires a Q4 operating margin of about 7.0%, above the 5.9% Q3 cumulative margin., Tax-rate risk: the 33.0% effective tax rate is above the typical Japanese statutory corporate tax range and reduced the tax burden to 0.663. A persistently elevated tax rate would restrain net-income growth relative to operating-profit growth..
Key concerns include SG&A expenses rose 2.4% YoY while revenue declined 0.9%, creating negative operating leverage and a 44bp operating-margin contraction., Corporate expenses not allocated to segments increased ¥217m YoY to ¥1.239bn, reducing the conversion of segment profit into consolidated operating income., The prior-year period included a ¥474m gain on sales of investment securities, while the current period included only a ¥10m gain and a ¥44m impairment loss. This unfavorable comparison contributed to net income declining faster than ordinary income., Reported ROE of 5.5% remains below the 8% benchmark, indicating that capital efficiency needs improvement despite a strong balance sheet..
Investment Implications
Key takeaways include Core gas operations are resilient: revenue declined 0.8%, but segment profit increased 0.5% and the segment margin improved to 9.1%., Consolidated earnings pressure is concentrated in chemical-products margin erosion, a loss in other businesses, and higher corporate and SG&A costs., Gross-margin improvement demonstrates some pricing or cost-management resilience, but the operating-margin decline shows that fixed-cost absorption and overhead remain the central operational issue., The balance sheet is conservatively positioned, with a net-cash position of ¥17.870bn, a 231.5% current ratio, 12.6% debt-to-capital, and 69.21x interest coverage., Full-year guidance depends on an above-run-rate Q4 operating performance, making evidence of chemical margin recovery and overhead containment important..
Metrics to watch include Gas-business segment margin and volume trend, Chemical-products segment margin recovery from 4.0%, SG&A growth relative to revenue growth, Unallocated corporate expenses relative to consolidated operating income, Annualized receivable days, currently flagged at 71 days, Q4 operating margin required to achieve the ¥6.3bn full-year operating-income target, Dividend income, foreign-exchange gains, and investment-security valuation movements, Progress toward ¥40.00 full-year DPS and ¥80.96 EPS guidance.
Regarding relative positioning, The company combines a stable, higher-margin industrial-gas core with a conservative balance sheet and material investment-security holdings. Its financial resilience is stronger than its current return profile: liquidity, leverage, and interest coverage are robust, while reported ROE of 5.5% and a 5.9% operating margin indicate modest capital and earnings efficiency. Near-term relative performance will depend on whether the gas business can remain resilient while chemical-products margins and corporate-cost absorption improve.